We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

130 hedge funds and large institutions have $811M invested in Sarepta Therapeutics in 2015 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 44 increasing their positions, 39 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

153% more capital invested

Capital invested by funds: $321M → $811M (+$490M)

121% more call options, than puts

Call options by funds: $89.5M | Put options by funds: $40.5M

114% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 14

14% more funds holding

Funds holding: 114 → 130 (+16)

13% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 39

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
130
Holders Change
+16
Holders Change %
+14.04%
% of All Funds
3.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
30
Increased
44
Reduced
39
Closed
14
Calls
$89.5M
Puts
$40.5M
Net Calls
+$49M
Net Calls Change
+$21.2M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$16.7M
2
PA
Perceptive Advisors
New York
+$12.4M
3
Invesco
Invesco
Georgia
+$10.1M
4
Jennison Associates
Jennison Associates
New York
+$7.22M
5
EA
Emerald Advisers
Pennsylvania
+$7.16M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$15.7M
2
State Street
State Street
Massachusetts
-$12.4M
3
PC
PointState Capital
New York
-$3.58M
4
GIM
Granahan Investment Management
Massachusetts
-$3.27M
5
TCM
Tekla Capital Management
Massachusetts
-$3.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
CWAM
1
Columbia Wanger Asset Management
Illinois
$107M +$5.32M +260,277 +8%
PA
2
Perceptive Advisors
New York
$85.5M +$12.4M +604,876 +27%
Vanguard Group
3
Vanguard Group
Pennsylvania
$76.1M +$1.61M +78,763 +3%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$63.2M +$16.7M +818,779 +65%
State Street
5
State Street
Massachusetts
$48M -$12.4M -606,445 -28%
BFA
6
BlackRock Fund Advisors
California
$46.5M -$658K -32,159 -2%
BIT
7
BlackRock Institutional Trust
California
$33.7M -$1.24M -60,583 -5%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$28.5M -$15.7M -765,600 -45%
BA
9
BlackRock Advisors
Delaware
$19M +$385K +18,837 +3%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$18.3M +$2.64M +129,347 +27%
PC
11
PointState Capital
New York
$17.5M -$3.58M -175,000 -23%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$15.7M +$5.3M +259,288 +101%
Invesco
13
Invesco
Georgia
$15.4M +$10.1M +494,088 +3,925%
Northern Trust
14
Northern Trust
Illinois
$13.9M +$146K +7,161 +2%
HM
15
HealthCor Management
New York
$11.1M -$2M -97,700 -21%
Jennison Associates
16
Jennison Associates
New York
$10.7M +$7.22M +353,000 New
EA
17
Emerald Advisers
Pennsylvania
$10.7M +$7.16M +350,127 New
HCMT
18
Highland Capital Management (Texas)
Texas
$10.1M +$2.11M +103,085 +45%
Renaissance Technologies
19
Renaissance Technologies
New York
$8.98M -$2.07M -101,361 -26%
Wells Fargo
20
Wells Fargo
California
$8.6M -$280K -13,681 -5%
EMFAT
21
Emerald Mutual Fund Advisers Trust
Pennsylvania
$8.02M +$5.39M +263,520 New
EAM
22
Eventide Asset Management
Massachusetts
$7.88M – – –
Geode Capital Management
23
Geode Capital Management
Massachusetts
$7.41M +$396K +19,384 +9%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$7.35M +$270K +13,206 +6%
Group One Trading
25
Group One Trading
Illinois
$7.03M +$1.97M +96,347 +72%
1
2 3 4 5

SRPT Hedge Fund Activity: Q2 2015 in Review

130 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q2 2015, worth a combined $811M — up 153% from $321M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new SRPT positions and 14 closed out — a net gain of 16 holders — while 44 added to existing stakes and 39 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $16.7M. The largest seller was Point72 Asset Management, cutting an estimated $15.7M.

  • 130 institutional investors held Sarepta Therapeutics (SRPT) as of Q2 2015, up from 114 in Q1 2015.
  • Funds reported $811M of Sarepta Therapeutics stock for Q2 2015, up 153% quarter-over-quarter.
  • 30 funds opened new Sarepta Therapeutics positions in Q2 2015 and 14 closed out, a net change of +16 holders.
  • The largest Sarepta Therapeutics buyer in Q2 2015 was Fidelity Investments, an estimated $16.7M added.
  • The largest Sarepta Therapeutics seller in Q2 2015 was Point72 Asset Management, an estimated $15.7M sold.

Based on aggregated 13F filings for Q2 2015.